BIIB 241122 230.00C (BIIB241122C230000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BIIB241122C230000

Watchlist

0.00
0.000.00%

15min DelayTrading Nov 19 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Tuesday Market Falls, SMCI Flies, Big Box Retail Reports Mixed | Live Stock
Kevin Travers11:11 ET
Lupus Therapeutics Statement on Phase 3 PHOENYCS GO Positive Data in Moderate-To-Severe Systemic Lupus
PR Newswire11:01 ET
UCB, Biogen Present Results From PHOENYCS GO Study
TipRanksNov 19 05:55 ET
Biogen, Partner Say Late-Stage Trial of Lupus Erythematosus Drug Candidate Met Primary Endpoint
MT NewswiresNov 19 05:14 ET
UCB And Biogen Present Phase 3 Data On Dapirolizumab Pegol, Showing Significant Lupus Activity Reduction
BenzingaNov 19 01:27 ET
Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today
Kevin TraversNov 18 16:21 ET

Comments

J-Eazy

Nov 15 13:08

garabage

this stock is 🗑️
$Biogen (BIIB.US)$

QMengColdJoke

Nov 14 10:04

? you just saved world?

$Biogen (BIIB.US)$

Movers and Shakers

Oct 30 07:28

Columns Today's Pre-Market Movers and Top Ratings | GOOGL, AMD, V, LLY and More

Morning Movers
Gapping up
$Alphabet-A (GOOGL.US)$ stock rose 6.3% following third-quarter results that exceeded expectations, with a notable increase in advertising revenue, which alleviated concerns over competition from AI-driven search products.
$Biogen (BIIB.US)$ stock increased 1.2% after the biotech company raised its annual earnings forecast and reported third-quarter earnings that surpassed both top and bottom line expe...

Movers and Shakers

Aug 1 07:27

Columns Today's Morning Movers and Top Ratings: META, ARM, MRNA, SHAK and More

Morning Movers
Gapping up
$Meta Platforms (META.US)$ stock rose 8.9% following stronger-than-expected second-quarter earnings and a positive future outlook.
$ConocoPhillips (COP.US)$ stock increased by 0.8% after reporting a second-quarter profit that surpassed estimates, aided by higher output and oil prices.
$Ferrari (RACE.US)$ stock climbed 3.3% as the company raised its full-year revenue and core earnings forecasts, having ex...